Application Sponsors
ANDA 201450 | HETERO LABS LTD III | |
Marketing Status
Application Products
001 | SOLUTION;ORAL | EQ 10MG BASE/5ML | 0 | CITALOPRAM HYDROBROMIDE | CITALOPRAM HYDROBROMIDE |
FDA Submissions
N/A; Not Applicable | ORIG | 1 | AP | 2015-12-15 | |
LABELING; Labeling | SUPPL | 3 | AP | 2020-04-20 | STANDARD |
LABELING; Labeling | SUPPL | 4 | AP | 2021-09-21 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 7 |
SUPPL | 3 | Null | 15 |
SUPPL | 4 | Null | 15 |
TE Codes
CDER Filings
HETERO LABS LTD III
cder:Array
(
[0] => Array
(
[ApplNo] => 201450
[companyName] => HETERO LABS LTD III
[docInserts] => ["",""]
[products] => [{"drugName":"CITALOPRAM HYDROBROMIDE","activeIngredients":"CITALOPRAM HYDROBROMIDE","strength":"EQ 10MG BASE\/5ML","dosageForm":"SOLUTION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"12\/15\/2015","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Not Applicable","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] => [{"actionDate":"04\/20\/2020","submission":"SUPPL-3","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[]","notes":"> Label is not available on this site."}]
[actionDate] => 2020-04-20
)
)